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Renal Dysplasia
Halana Whitehead, M.D.

Overview
Renal dysplasia (RD) is characterized by abnormal differentiation of the nephrons and collecting
ducts, decreased nephron number, increased stromal elements and the presence of metaplastic
tissues such as cartilage.1–3 RD is part of a group of disorders known as Congenital Anomalies
of the Kidney and Urinary Tract (CAKUT). These disorders represent approximately 70% of
pediatric chronic kidney disease.3 Dyplastic kidneys vary in size and in the presence of cysts.
The spectrum of RD ranges from small- or normal-sized kidneys, with or without cysts, to
markedly enlarged kidneys with significant cystic changes.2 An extreme phenotype of RD are
multicystic dysplastic kidneys (MCDK). Renal hypodysplasia refers to small dysplastic kidneys
without gross cystic changes.3

Epidemiology
Unilateral RD occurs in 1 in every 3,000 to 5,000 births and bilateral dysplasia occurs in 1 in
every 10,000 births.1,3 The incidence of CAKUT in general is 0.3 to 1.6 per 1,000 births.3
Bilateral RD, in particular hypodysplasia, is the most common cause of chronic renal failure in
childhood and has been reported to account for 25% of pediatric patients requiring renal
replacement therapy.1,4

Pathogenesis
The pathogenesis of RD is multifactorial with numerous causes thus far identified including
genetic mutations and drug exposures, but in most cases a cause is never identified.

In

humans, kidney development begins at 4 weeks gestation in a sequential pattern.

Two

transient structures, the pronephros and mesonephros, develop prior to the formation of the
metanephros. The metanephros is a permanent embryologic structure which develops into the
mature kidney. The initial step of metanephric development is the formation of the ureteric bud.
This is an out-growth of epithelial cells from the distal aspect of the Wolffian duct. The ureteric
bud continues to grow from the reciprocal interactions of the ureteric epithelium and the
surrounding metanephric mesenchyme. This reciprocal interaction induces branching
morphogenesis in a stereotypic pattern of kidney formation. When the ureteric bud develops in
an abnormal location this alters the interaction between the ureteric bud and the metanephric
mesenchyme leading to abnormal renal differentiation and RD.5,6 RD also develops when lower
urinary tract obstruction occurs during fetal development. Lower urinary tract obstruction in
animal models has caused renal dysplasia, but the cystic changes seen in these models are
less prominent. Metaplastic tissues are absent, demonstrating that there are likely additional
factors at play in human disease.1

Studies have also demonstrated an imbalance of cell

proliferation and programmed cell death in human RD. Proliferative factors such as PAX2 and
BCL2 are overexpressed in cystic epithelia in RD. Dysplastic kidneys have also been shown to
have more apoptotic cells than their normal counterparts which may explain the tendency for
involution in RD.6

Genetics
The majority of human RD occurs sporadically, but some studies have found clustering of renal
abnormalities in families of patients with severe RD.2 The most common renal abnormality seen
with a familial pattern is unilateral agenesis, which, given RD’s tendency to involute, may
represent a history of unilateral RD.2

Numerous syndromes are associated with RD and CAKUT, including Beckwith-Wiedemann,
DiGeorge, Meckel-Gruber and Fanconi anemia. Of particular interest is an entity known as
Renal Cysts and Diabetes (RCAD) syndrome which is caused by mutations in the transcription
factor HNF1b.

RCAD features glucose intolerance or diabetes and renal malformations

including RD, polycystic kidneys and solitary kidney. Uterine malformations have been reported
in women with RCAD.

RCAD can occur secondary to a de novo mutation or inherited in a

dominant pattern.1,6 RCAD may go undiagnosed in families until a child with a more severe
renal phenotype is born. Additionally, mutations in the gene encoding HNF1b have been seen
in patients with prenatally diagnosed renal abnormalities even in the absence of a family history
concerning for RCAD.1
Additional genes implicated in RD included PAX2 and uroplakins. PAX2 has been shown in
mouse models to cause renal agenesis in null mutants and renal hypoplasia in heterozygotes.
PAX2 overexpression has been shown to cause RD and cystic changes. PAX2 mutations in
humans cause renal-coloboma syndrome andhave also been associated with hypertension.1
Uroplakins are a group of proteins expressed on the urothelial surface. Uroplakin II and IIIA
mutations have been demonstrated in patients with severe RD and uroplakin mutations have
also been linked to VUR.1

Diagnosis and Clinical Presentation
RD is technically a histologic diagnosis, but can be deduced from imaging, particularly
ultrasonography.2

RD is often first identified on prenatal ultrasonography. CAKUT represent

one third of abnormalities detected on routine prenatal ultrasound.6 A study by Fraser et al. of
53 RD patients in the U.K. reported that 60% were diagnosed by prenatal ultrasonography, with
the majority detected during the 20 week anatomic survey.7

Features of prenatally diagnosed RD include renal size discrepancy, renal pelvic dilation, and
cystic changes.1,2,7 Dysplastic kidneys can be small or enlarged, although there is likely an
early diagnostic bias for enlarged kidneys, which are easier to visualize.1,2 When one kidney is
noted to be abnormal, a careful examination of the contralateral kidney is required as 30-50%
will have additional abnormalities.2 Decreased amniotic fluid volume is associated with severe
bilateral disease and often leads to an earlier diagnosis of RD.1,2

RD may also be associated

with lower urinary tract abnormalities. Bilateral MCDK in particular is often associated with
ureteric atresia.2 It is important to note that the renal phenotype can evolve over the course of
the pregnancy. Resolution occurs in some cases, but abnormalities may also become more
prominent.1,2
When there is concern for RD on prenatal ultrasound, a detailed anatomic assessment of the
fetus should be performed as one third have abnormalities in other organ systems.2
Assessment for additional anomalies is also important to evaluate the potential for a multi-organ
system genetic syndrome as the cause.
chromosomal analysis is indicated.1,2

Additional abnormalities may determine if

Further work-up for prenatally diagnosed RD should

include a detailed family history for both renal disease and conditions such as diabetes to
assess for inherited causes and risk of disease in future children. Renal ultrasound screening of
first-degree relatives should also be considered.2 Assessment for inherited causes is important
both for the fetus’s prognosis and for assessing recurrence risk with future pregnancies, which
is low in the absence of inherited causes (approximately 2-3%).2
When RD is not diagnosed prior to birth, diagnosis often occurs in the neonatal period when an
ultrasound is ordered due concerning physical exam findings (abdominal mass, palpable
bladder, etc.), laboratory abnormalities (mainly elevated creatinine) or the presence of
conditions associated with renal abnormalities which prompt screening.7 The Fraser et al. study

noted that of the 40% of patients diagnosed postnatally, half came to attention in the neonatal
period. Many of the remaining patients presented within the first two years of life with UTI.7

Management and Outcomes
The course and prognosis of RD depends primarily on 2 factors: 1) whether the patient’s RD
associated with a genetic syndrome and 2) whether the RD is unilateral or bilateral. In the case
of RD associated with a syndrome, the prognosis is largely dependent on the presence of extrarenal abnormalities such as cardiac and neurologic disease.1
In the case of isolated/(non-syndromic) RD, bilateral RD carries a worse prognosis, particularly
if it associated with oligohydramnios and poor renal growth or involution in utero. This can lead
to pulmonary hypoplasia (Potter’s sequence) and many infants die in the neonatal period from
respiratory failure. In cases of less severe pulmonary disease, but with poor kidney function
dialysis can be considered but is technically difficult in neonates.1,2 In patients with less severe
bilateral RD, the onset of renal failure is usually later, making renal replacement therapy easier
to manage and, once a child is 10 kg or greater, renal transplant becomes a therapeutic
option.1,2
Unilateral RD has a significantly better prognosis, particularly if the contralateral kidney is
normal. Most dysplastic kidneys ultimately involute without issue. This results in compensatory
hypertrophy of the contralateral kidney. 2 Compensatory hypertrophy may even begin
prenatally. In the majority of patients with isolated unilateral disease, renal failure and
decreased renal function do not develop, but nearly half have hypertension in adulthood.2
Historically it was believed that the dysplastic kidney conferred an increased risk of renal
tumors, but this has not borne out in more recent studies. As such, elective nephrectomy is no
longer recommended unless there is another indication.1,2

While prognosis is difficult to determine prenatally, post-natal glomerular filtration rate (GFR)
has been shown to have some predictive value. A GFR <15 mL/min per 1.73m2 at 6 months or
<25 mL/min per 1.73m2 at 18 months has been associated with a worse prognosis, although
more recent studies indicate that GFR at age 5 may be more predictive of long-term renal
function due to delayed renal growth.1,2 Additionally, poor postnatal renal growth in both
unilateral and bilateral RD, renal scarring and the presence of posterior urethral valves or VUR
are associated with poorer outcomes.7 In cases of RD associated with lower urinary tract
obstruction, prognosis cannot be determined until after the obstruction is corrected.2
In both unilateral and bilateral RD, referral to a pediatric nephrologist should be made promptly
after the diagnosis of RD so that progression and renal growth can be closely monitored. In the
case of certain lower urinary tract abnormalities such as vesicoureteral reflux (VUR), antibiotic
prophylaxis may be indicated to prevent UTI and subsequent renal scarring.1 The role of other
medications in RD remains unclear. ACE inhibitors and ARBs may help improve long-term
renal function in RD, as they do in adults with proteinuric CKD, but this has not been wellstudied to date.2
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